University of California Irvine 15th Annual Orange County Symposium for Cardiovascular Disease Prevention 2023 (Videos + PDFs)

Preventive Cardiology, Lipid Management & Cardiovascular Risk Reduction Update

Overview

University of California Irvine (UCI) 15th Annual Orange County Symposium for Cardiovascular Disease Prevention 2023 is a comprehensive preventive cardiology conference focused on the latest evidence-based strategies for reducing cardiovascular risk and improving long-term patient outcomes.

Held on October 28, 2023, at the UCI Susan & Henry Samueli College of Health Sciences, this symposium brings together leading experts in cardiology, endocrinology, lipidology, obesity medicine, diabetes care, and lifestyle medicine to address one of healthcare’s greatest challenges: the prevention of cardiovascular disease before clinical events occur.

Under the theme “A Pre-emptive Strike: Addressing Cardiovascular Disease Through Preventive Strategies,” the conference provides practical guidance on risk assessment, lipid management, diabetes therapies, obesity treatment, hypertension control, lifestyle interventions, and emerging preventive cardiology therapies.

This educational package includes 12 video lectures and 14 PDF presentations, delivering actionable clinical updates for healthcare professionals involved in cardiovascular prevention.

Course Highlights

• 12 Expert-Led Video Lectures
• 14 Downloadable PDF Presentations
• Preventive Cardiology Focus
• Cardiovascular Risk Reduction Strategies
• Lipid Management Updates
• Diabetes & Cardiovascular Disease Education
• Obesity Medicine & Weight Management
• Lifestyle Intervention Approaches
• Evidence-Based Clinical Guidelines
• Multidisciplinary Cardiovascular Prevention Education

Learning Objectives

Upon completion of this course, participants will be able to:

• Apply modern preventive cardiology principles in clinical practice.
• Identify patients at elevated cardiovascular risk.
• Utilize current lipid management strategies to reduce cardiovascular events.
• Evaluate the role of diabetes therapies in cardiovascular prevention.
• Implement evidence-based approaches to hypertension management.
• Understand emerging treatments for dyslipidemia and atherosclerosis.
• Develop comprehensive cardiovascular prevention programs.
• Integrate lifestyle interventions into routine patient care.
• Assess obesity-related cardiovascular risk and treatment options.
• Apply current clinical guidelines for primary and secondary prevention.

Major Topics Covered

Preventive Cardiology

The symposium focuses on proactive strategies designed to prevent cardiovascular disease before major clinical events occur.

Topics Include

• Primary prevention
• Secondary prevention
• Cardiovascular risk assessment
• Early intervention strategies
• Population health approaches
• Risk factor modification

Participants learn practical methods to reduce cardiovascular morbidity and mortality.

Lipid Management & Dyslipidemia

A major component of the conference reviews modern approaches to cholesterol management.

Topics Include

• LDL cholesterol reduction
• Lipoprotein(a) [Lp(a)]
• Familial hypercholesterolemia
• Statin therapy
• Non-statin lipid therapies
• PCSK9 inhibitors
• Emerging lipid-lowering agents

Faculty discuss the latest evidence supporting aggressive lipid management for cardiovascular risk reduction.

Diabetes & Cardiovascular Disease

The symposium explores the close relationship between diabetes and cardiovascular outcomes.

Covered Topics

• Type 2 diabetes management
• Cardiovascular risk in diabetes
• SGLT2 inhibitors
• GLP-1 receptor agonists
• Cardiometabolic disease
• Diabetes prevention strategies

Participants gain practical insights into selecting therapies that provide both glycemic and cardiovascular benefits.

Obesity Medicine & Weight Management

Obesity remains a major contributor to cardiovascular disease.

Topics Include

• Obesity-related cardiovascular risk
• Weight-loss therapies
• Lifestyle modification
• Pharmacologic obesity treatment
• Cardiometabolic health
• Long-term weight management

Faculty review modern treatment approaches that improve both metabolic and cardiovascular outcomes.

Hypertension Management

Current strategies for blood pressure control are discussed in detail.

Covered Areas

• Hypertension guidelines
• Resistant hypertension
• Blood pressure targets
• Cardiovascular risk reduction
• Lifestyle interventions
• Pharmacologic treatment optimization

Participants learn how effective blood pressure management reduces long-term cardiovascular events.

Lifestyle Medicine & Risk Factor Modification

The conference emphasizes the importance of lifestyle interventions as foundational cardiovascular therapies.

Topics Include

• Nutrition and heart health
• Physical activity recommendations
• Smoking cessation
• Sleep health
• Stress management
• Behavioral interventions

These sessions provide practical tools for implementing sustainable lifestyle changes.

Atherosclerotic Cardiovascular Disease (ASCVD)

The program reviews contemporary understanding of atherosclerosis and vascular disease prevention.

Topics Include

• Coronary artery disease prevention
• Atherosclerosis progression
• Inflammation and cardiovascular risk
• Plaque stabilization
• Risk prediction models
• Preventive therapies

Participants gain a deeper understanding of mechanisms driving cardiovascular disease.

Emerging Therapies & Future Directions

The symposium highlights innovative therapies that are reshaping preventive cardiology.

Topics Include

• Novel lipid-lowering medications
• Precision cardiovascular medicine
• Cardiometabolic therapeutics
• Preventive imaging
• Future prevention strategies
• Ongoing clinical trials

These sessions prepare clinicians for the next generation of cardiovascular prevention.

Evidence-Based Guidelines

Faculty review contemporary clinical guidelines relevant to preventive cardiology.

Discussion Areas

• ACC/AHA prevention guidelines
• Lipid management recommendations
• Diabetes treatment pathways
• Obesity management guidelines
• Hypertension recommendations
• Risk assessment tools

The focus remains on translating evidence into everyday clinical practice.

Educational Features

✔ Comprehensive preventive cardiology update

✔ Lipidology and dyslipidemia education

✔ Cardiometabolic disease management

✔ Obesity medicine updates

✔ Hypertension management strategies

✔ Diabetes and cardiovascular risk reduction

✔ Lifestyle medicine integration

✔ Emerging preventive therapies

✔ Evidence-based clinical guidance

✔ Multidisciplinary expert faculty

Who Should Attend?

This course is ideal for:

• Cardiologists
• Preventive Cardiologists
• Endocrinologists
• Internal Medicine Physicians
• Primary Care Physicians
• Family Medicine Physicians
• Lipid Specialists
• Nurse Practitioners
• Physician Assistants
• Fellows and Residents
• Healthcare Professionals Interested in Cardiovascular Prevention

Why This Course Stands Out

✔ Dedicated focus on preventive cardiology

✔ Strong emphasis on practical clinical application

✔ Comprehensive lipid management education

✔ Integrates cardiology, endocrinology, and lifestyle medicine

✔ Reviews emerging therapies and clinical trials

✔ Covers obesity, diabetes, and hypertension management

✔ Evidence-based guideline updates

✔ Designed to improve long-term cardiovascular outcomes

✔ Applicable to both specialty and primary care practice

✔ Led by nationally recognized prevention experts

 Topics:

• Clinical Questions in Cardiology-Using Glucagon-like Peptide-1 Receptor Agonists Flyer-v20230905.pdf
• Session I HFpEF vs. HfrEF State of the Art Prevention and Treatment.mp4
• Session I HFpEF vs. HfrEF State of the Art Prevention and Treatment.pdf
• Session I Integrative Therapies to Control Hypertension and Cardiovascular Disease.mp4
• Session I Integrative Therapies to Control Hypertension and Cardiovascular Disease.pdf
• Session I Nutraceuticals in Heart Failure Prevention.mp4
• Session I Nutraceuticals in Heart Failure Prevention.pdf
• Session I Reducing Cardiometabolic Risk with SGLT2i and GLP1-RA – How to Choose and in Who.mp4
• Session I Reducing Cardiometabolic Risk with SGLT2i and GLP1-RA – How to Choose and in Who.pdf
• Session II HDL-C The Misunderstood Lipoprotein.mp4
• Session II HDL-C The Misunderstood Lipoprotein.pdf
• Session II Keynote Lecture The Imperative to Move Towards Value Based Cardiovascular Care.mp4
• Session II Keynote Lecture The Imperative to Move Towards Value Based Cardiovascular Care.pdf
• Session II Newer Recommendations, Therapies, and Evidence for Improving Lipid Control and Cardiovascular Outcomes.mp4
• Session II Newer Recommendations, Therapies, and Evidence for Improving Lipid Control and Cardiovascular Outcomes.pdf
• Session II Pillars of Therapy for Prevention of CVD in CKD Patients – the Cardiorenal Syndrome.mp4
• Session II Pillars of Therapy for Prevention of CVD in CKD Patients – the Cardiorenal Syndrome.pdf
• Session III Benefits and Powers of Physical Activity and Cardiac Rehab – Empowering your Patients.mp4
• Session III Benefits and Powers of Physical Activity and Cardiac Rehab – Empowering your Patients.pdf
• Session III LDL-C Earlier and Lower is Better and Safer.mp4
• Session III LDL-C Earlier and Lower is Better and Safer.pdf
• Session III Pregnancy and Reproductive Risk Enhancing Factors for Women.mp4
• Session III Pregnancy and Reproductive Risk Enhancing Factors for Women.pdf
• Session III Sleep The Eighth Life’s Essential.mp4
• Session III Sleep The Eighth Life’s Essential.pdf
• Session III The Penis and the Heart An Intimate Connection.pdf